Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bybee Clinton
Relationship:   10% Owner
City:   Chicago
State:   IL
   
Insider Summary:
  
   
Companies Owned :   20    
Direct Shares   37,071,986    

Indirect Shares

   66,802,916      
Direct Value   $304,422,768    

Indirect Value

   $788,668,383      
Total Shares   103,874,902      
Total Value   $1,093,091,151      


Illumina Inc $697,485 Kythera Biopharmaceuticals Inc $0 Fate Therapeutics Inc $9,398,114 Agios Pharmaceuticals Inc $97,259,699 Sage Therapeutics, Inc. $0 Juno Therapeutics, Inc. $0 Bellerophon Therapeutics Inc $269,129 Syros Pharmaceuticals, Inc. $23,371,170 Impinj Inc $2,584,334 Denali Therapeutics Inc. $170,790,797 Beam Therapeutics Inc. $52,039 Vir Biotechnology, Inc. $0 Illumina Inc $697,485 Kythera Biopharmaceuticals Inc $0 Fate Therapeutics Inc $9,398,114 Agios Pharmaceuticals Inc $97,259,699 Sage Therapeutics, Inc. $0 Juno Therapeutics, Inc. $0 Bellerophon Therapeutics Inc $269,129 Syros Pharmaceuticals, Inc. $23,371,170 Impinj Inc $2,584,334 Denali Therapeutics Inc. $170,790,797 Beam Therapeutics Inc. $52,039 Vir Biotechnology, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    1   
    0    
   
     Gain/Loss Ratio :
   -1.0   
   0.0   
     Percentage Gain/Loss :
   -24.4%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Illumina Inc ILMN Former 10% Holder 2004-02-03 5,704 2004-02-03 2,915,298    Premium*  
            Alnylam Pharmaceuticals Inc ALNY 10% Owner 0 2004-05-27 222,500    Premium*  
            Cyclacel Pharmaceuticals Inc CYCC 10% Owner 2004-03-19 0 2004-03-19 2,054,271    Premium*  
            Kythera Biopharmaceuticals Inc KYTH 10% Owner 2012-10-16 2,105,740 2012-10-16 0    Premium*  
            Fate Therapeutics Inc FATE 10% Owner 2013-10-04 2,473,188 2013-10-04 0    Premium*  
            Agios Pharmaceuticals Inc AGIO 10% Owner 2015-02-19 3,088,590 2014-06-23 0    Premium*  
            Sage Therapeutics, Inc. SAGE 10% Owner 2015-06-18 2,124,699 2014-07-23 0    Premium*  
            Juno Therapeutics, Inc. JUNO 10% Owner 2016-03-15 10,552,390 0    Premium*  
            Bellerophon Therapeutics Inc BLPH 10% Owner 2015-02-19 965,660 0    Premium*  
            Xtera Communications, Inc. XCOM Director, 10% Owner 0 2015-11-17 1,885,090    Premium*  
            Syros Pharmaceuticals, Inc. SYRS 10% Owner 2016-07-06 4,637,137 0    Premium*  
            Impinj Inc PI Director 2020-10-23 17,125 2019-11-15 0    Premium*  
            Denali Therapeutics Inc. DNLI 10% Owner 2017-12-12 11,068,749 2017-12-12 0    Premium*  
            Unity Biotechnology Inc UBX 10% Owner 2018-05-07 0 2018-05-07 1,682,417    Premium*  
            Gossamer Bio Inc GOSS 10% Owner 2019-02-12 0 2019-02-12 4,027,958    Premium*  
            Karuna Therapeutics, Inc. KRTX 10% Owner 2019-07-02 0 2019-07-02 1,681,435    Premium*  
            Beam Therapeutics Inc. BEAM 10% Owner 2021-03-31 2,434 2021-03-31 3,521,519    Premium*  
            Vir Biotechnology, Inc. VIR 10% Owner 2022-09-06 30,570 2022-09-06 61,160    Premium*  
            Lyell Immunopharma, Inc. LYEL 10% Owner 2021-06-21 0 2021-06-21 18,206,358    Premium*  
            Neumora Therapeutics, Inc. NMRA 10% Owner 0 2023-12-08 30,544,910    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
NMRA Neumora Therapeutics, Inc... 10% Owner   –       –       •   2023-12-08 4 A $0.00 $0 I/I 1,879,654 2,321,566 0 -
NMRA Neumora Therapeutics, Inc... 10% Owner   –       –       •   2023-09-19 4 B $17.00 $25,500,000 I/I 1,500,000 3,624,143 1.5 %
NMRA Neumora Therapeutics, Inc... 10% Owner   –       –       •   2023-09-19 4 A $0.00 $0 I/I 17,424,704 2,124,143 0 -
NMRA Neumora Therapeutics, Inc... 10% Owner   –       –       •   2023-09-14 3 IO $0.00 $0 I/I 0 10,620,716 -
VIR Vir Biotechnology, Inc. 10% Owner   –       –       •   2022-09-06 4 A $0.00 $0 I/I 3,248 61,160 0 -
VIR Vir Biotechnology, Inc. 10% Owner   –       –       •   2022-09-06 4 A $0.00 $0 D/D 16,007 30,570 0 -
VIR Vir Biotechnology, Inc. 10% Owner   –       –       •   2022-09-06 4 D $0.00 $0 I/I (550,000) 7,290,655 0 -
VIR Vir Biotechnology, Inc. 10% Owner   –       –       •   2022-09-02 4 A $0.00 $0 I/I 2,662 57,912 0 -
VIR Vir Biotechnology, Inc. 10% Owner   –       –       •   2022-09-02 4 D $0.00 $0 I/I (450,000) 7,601,096 0 -
VIR Vir Biotechnology, Inc. 10% Owner   –       –       •   2022-09-02 4 A $0.00 $0 D/D 13,101 28,946 0 -
VIR Vir Biotechnology, Inc. 10% Owner   –       –       •   2022-08-31 4 A $0.00 $0 I/I 2,952 55,250 0 -
VIR Vir Biotechnology, Inc. 10% Owner   –       –       •   2022-08-31 4 A $0.00 $0 D/D 14,551 27,608 0 -
VIR Vir Biotechnology, Inc. 10% Owner   –       –       •   2022-08-31 4 D $0.00 $0 I/I (500,000) 7,855,093 0 -
VIR Vir Biotechnology, Inc. 10% Owner   –       –       •   2022-08-30 4 D $0.00 $0 I/I (500,000) 8,137,312 0 -
VIR Vir Biotechnology, Inc. 10% Owner   –       –       •   2022-08-30 4 A $0.00 $0 D/D 14,551 26,133 0 -
VIR Vir Biotechnology, Inc. 10% Owner   –       –       •   2022-08-30 4 A $0.00 $0 I/I 2,952 52,298 0 -
VIR Vir Biotechnology, Inc. 10% Owner   –       –       •   2022-08-25 4 A $0.00 $0 I/I 2,952 49,346 0 -
VIR Vir Biotechnology, Inc. 10% Owner   –       –       •   2022-08-25 4 A $0.00 $0 D/D 14,551 24,658 0 -
VIR Vir Biotechnology, Inc. 10% Owner   –       –       •   2022-08-25 4 D $0.00 $0 I/I (500,000) 8,419,531 0 -
VIR Vir Biotechnology, Inc. 10% Owner   –       –       •   2022-08-24 4 D $0.00 $0 I/I (500,000) 8,701,750 0 -
VIR Vir Biotechnology, Inc. 10% Owner   –       –       •   2022-08-24 4 A $0.00 $0 D/D 14,551 23,183 0 -
VIR Vir Biotechnology, Inc. 10% Owner   –       –       •   2022-08-24 4 A $0.00 $0 I/I 2,952 46,394 0 -
VIR Vir Biotechnology, Inc. 10% Owner   –       –       •   2022-08-18 4 A $0.00 $0 I/I 2,952 43,442 0 -
VIR Vir Biotechnology, Inc. 10% Owner   –       –       •   2022-08-18 4 A $0.00 $0 D/D 14,551 21,708 0 -
VIR Vir Biotechnology, Inc. 10% Owner   –       –       •   2022-08-18 4 D $0.00 $0 I/I (500,000) 8,983,969 0 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us